These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. MAPK Pathway Inhibitors Sensitize BRAF-Mutant Melanoma to an Antibody-Drug Conjugate Targeting GPNMB. Rose AA; Annis MG; Frederick DT; Biondini M; Dong Z; Kwong L; Chin L; Keler T; Hawthorne T; Watson IR; Flaherty KT; Siegel PM Clin Cancer Res; 2016 Dec; 22(24):6088-6098. PubMed ID: 27515299 [TBL] [Abstract][Full Text] [Related]
14. Role of the mitogen-activated protein kinase signaling pathway in the regulation of human melanocytic antigen expression. Kono M; Dunn IS; Durda PJ; Butera D; Rose LB; Haggerty TJ; Benson EM; Kurnick JT Mol Cancer Res; 2006 Oct; 4(10):779-92. PubMed ID: 17050671 [TBL] [Abstract][Full Text] [Related]
15. Simultaneous suppression of MITF and BRAF V600E enhanced inhibition of melanoma cell proliferation. Kido K; Sumimoto H; Asada S; Okada SM; Yaguchi T; Kawamura N; Miyagishi M; Saida T; Kawakami Y Cancer Sci; 2009 Oct; 100(10):1863-9. PubMed ID: 19659611 [TBL] [Abstract][Full Text] [Related]
16. An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition. Young HL; Rowling EJ; Bugatti M; Giurisato E; Luheshi N; Arozarena I; Acosta JC; Kamarashev J; Frederick DT; Cooper ZA; Reuben A; Gil J; Flaherty KT; Wargo JA; Vermi W; Smith MP; Wellbrock C; Hurlstone A J Exp Med; 2017 Jun; 214(6):1691-1710. PubMed ID: 28450382 [TBL] [Abstract][Full Text] [Related]
17. Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy. Wellbrock C; Arozarena I Pigment Cell Melanoma Res; 2015 Jul; 28(4):390-406. PubMed ID: 25818589 [TBL] [Abstract][Full Text] [Related]